Rankings
▼
Calendar
ALKS FY 2020 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena
ALKS
Alkermes plc
$5B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1.0B
-11.3% YoY
Gross Profit
$860M
82.8% margin
Operating Income
-$112M
-10.8% margin
Net Income
-$111M
-10.7% margin
EPS (Diluted)
$-0.70
Cash Flow
Operating Cash Flow
$83M
Free Cash Flow
$41M
Stock-Based Comp.
$90M
Balance Sheet
Total Assets
$1.9B
Total Liabilities
$883M
Stockholders' Equity
$1.1B
Cash & Equivalents
$273M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.0B
$1.2B
-11.3%
Gross Profit
$860M
$991M
-13.1%
Operating Income
-$112M
-$175M
+35.9%
Net Income
-$111M
-$197M
+43.6%
← Q4 2019
All Quarters
Q1 2020 →